Tech VCs are flush with money and starting to look at healthcare as an opportunity. They are staying close to what they know — healthcare IT/dhealth/big data – but a few are venturing beyond that into more traditional biotech.  Hear a panel speak about what they see as opportunities and how they are sourcing deals